What is NDC 70954-151?

70954-151 is the product NDC for Naproxen Oral Suspension (naproxen oral), Naproxen 125 mg/5mL suspension, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Naproxen Oral Suspension (Naproxen oral).

ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naproxen Oral Suspension?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naproxen Oral Suspension NDC 70954-151

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-151Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0151Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-151-10	70954015110	500 mL in 1 BOTTLE (70954-151-10)Marketed from Mar 12, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen Oral Suspension
Generic name (nonproprietary): naproxen oral
Active ingredients: Naproxen — 125 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.NDC labeler code 70954
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211910
Marketing start: Mar 12, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 70954-151_1aa670cb-8d65-413a-9bdd-680cafd9b5c4SPL ID 1aa670cb-8d65-413a-9bdd-680cafd9b5c4SPL set ID 252726a7-757a-4b97-b5b8-ffff4ac1d103RxCUI 311913UNII 57Y76R9ATQUPC 0370954151104
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954015110 followed by a unit qualifier and the quantity

Package 70954-0151-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 25, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Naproxen oral suspension is indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis tendonitis bursitis acute gout the management of: pain. primary dysmenorrhea Naproxen oral suspension is a non-steroidal anti-inflammatory drug indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis tendonitis bursitis acute gout the management of: pain. primary dysmenorrhea

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70954-151

What is NDC 70954-151?: 70954-151 is the product NDC for Naproxen Oral Suspension (naproxen oral), Naproxen 125 mg/5mL suspension, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naproxen Oral Suspension (Naproxen oral).
What is the active ingredient?: Naproxen.
Who is the labeler?: ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naproxen Oral Suspension?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Naproxen Oral Suspension (Naproxen oral) NDC 70954-151